These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 2451560)

  • 1. Role of folylpolyglutamate synthetase in the regulation of methotrexate polyglutamate formation in H35 hepatoma cells.
    Johnson TB; Nair MG; Galivan J
    Cancer Res; 1988 May; 48(9):2426-31. PubMed ID: 2451560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells.
    Rhee MS; Galivan J; Wright JE; Rosowsky A
    Mol Pharmacol; 1994 Apr; 45(4):783-91. PubMed ID: 7514264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DL-beta,beta-difluoroglutamic acid mediates position-dependent enhancement or termination of pteroylpoly(gamma-glutamate) synthesis catalyzed by folylpolyglutamate synthetase.
    McGuire JJ; Hart BP; Haile WH; Rhee MS; Galivan J; Coward JK
    Arch Biochem Biophys; 1995 Aug; 321(2):319-28. PubMed ID: 7646057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. gamma-Glutamyl hydrolase and folylpolyglutamate synthetase activities predict polyglutamylation of methotrexate in acute leukemias.
    Longo GS; Gorlick R; Tong WP; Lin S; Steinherz P; Bertino JR
    Oncol Res; 1997; 9(5):259-63. PubMed ID: 9306433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquisition of resistance to antifolates caused by enhanced gamma-glutamyl hydrolase activity.
    Rhee MS; Wang Y; Nair MG; Galivan J
    Cancer Res; 1993 May; 53(10 Suppl):2227-30. PubMed ID: 7683570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory aspects of the glutamylation of methotrexate in cultured hepatoma cells.
    Nimec Z; Galivan J
    Arch Biochem Biophys; 1983 Oct; 226(2):671-80. PubMed ID: 6195970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic parenchymal cell glutamylation of methotrexate studied in monolayer culture.
    Galivan J; Pupons A; Rhee MS
    Cancer Res; 1986 Feb; 46(2):670-5. PubMed ID: 2416430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate analogues as substrates of mammalian folylpolyglutamate synthetase.
    Schoo MM; Pristupa ZB; Vickers PJ; Scrimgeour KG
    Cancer Res; 1985 Jul; 45(7):3034-41. PubMed ID: 3873989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism-based inhibition of human folylpolyglutamate synthetase: design, synthesis, and biochemical characterization of a phosphapeptide mimic of the tetrahedral intermediate.
    Tsukamoto T; Haile WH; McGuire JJ; Coward JK
    Arch Biochem Biophys; 1998 Jul; 355(1):109-18. PubMed ID: 9647673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of folylpolyglutamate synthetase and gamma-glutamyl hydrolase in altering cellular folyl- and antifolylpolyglutamates.
    Galivan J; Johnson T; Rhee M; McGuire JJ; Priest D; Kesevan V
    Adv Enzyme Regul; 1987; 26():147-55. PubMed ID: 3499766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of methotrexate polyglutaminate formation in Ehrlich ascites carcinoma cells by endogenous folate pool.
    Balińska M
    Acta Biochim Pol; 1986; 33(1):31-7. PubMed ID: 2424199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of gamma-glutamyl hydrolase on folyl and antifolylpolyglutamates in cultured H35 hepatoma cells.
    Yao R; Rhee MS; Galivan J
    Mol Pharmacol; 1995 Sep; 48(3):505-11. PubMed ID: 7565632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate analog nonsubstrates and inhibitors of folylpolyglutamate synthetase as potential cancer chemotherapy drugs.
    McGuire JJ; Piper JR; Coward JK; Galivan J
    NCI Monogr; 1987; (5):139-44. PubMed ID: 2448652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depletion of 5,10-methylenetetrahydrofolate and 10-formyltetrahydrofolate by methotrexate in cultured hepatoma cells.
    Rhee MS; Coward JK; Galivan J
    Mol Pharmacol; 1992 Nov; 42(5):909-16. PubMed ID: 1435754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrolytic cleavage of methotrexate gamma-polyglutamates by folylpolyglutamyl hydrolase derived from various tumors and normal tissues of the mouse.
    Samuels LL; Goutas LJ; Priest DG; Piper JR; Sirotnak FM
    Cancer Res; 1986 May; 46(5):2230-5. PubMed ID: 2421872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
    Westerhof GR; Schornagel JH; Kathmann I; Jackman AL; Rosowsky A; Forsch RA; Hynes JB; Boyle FT; Peters GJ; Pinedo HM
    Mol Pharmacol; 1995 Sep; 48(3):459-71. PubMed ID: 7565626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human liver folylpolyglutamate synthetase by non-gamma-glutamylatable antifolate analogs.
    Clarke L; Rosowsky A; Waxman DJ
    Mol Pharmacol; 1987 Jan; 31(1):122-7. PubMed ID: 3807889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamylation of methotrexate in hepatoma cells in vitro: regulation and the development of specific inhibitors.
    Galivan J; Nimec Z; Coward JK; McGuire JJ
    Adv Enzyme Regul; 1985; 23():13-23. PubMed ID: 2416193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of folinic acid on hepatoma cells containing methotrexate polyglutamates.
    Galivan J; Nimec Z
    Cancer Res; 1983 Feb; 43(2):551-5. PubMed ID: 6184149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme inhibition, polyglutamation, and the effect of LY231514 (MTA) on purine biosynthesis.
    Mendelsohn LG; Shih C; Chen VJ; Habeck LL; Gates SB; Shackelford KA
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):42-7. PubMed ID: 10598554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.